12:09 PM EDT, 04/28/2025 (MT Newswires) -- ImmunityBio ( IBRX ) said Monday its phase 2/3 trial of Anktiva plus Bacillus Calmette-Guerin in adults with BCG-unresponsive non-muscle invasive bladder cancer, with or without papillary disease, showed prolonged complete response and a relatively higher rate of cystectomy avoidance. The trial results, presented at the American Urological Association Annual Meeting in Las...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

12:08 PM EDT, 04/28/2025 (MT Newswires) -- Larry G Gerdes, Director, on April 24, 2025, sold 4,000 shares in CME Group ( CME ) for $1,060,441. Following the Form 4 filing with the SEC, Gerdes has control over a total of 36,651 Class A common shares of the company, with 36,651 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000100/xslF345X05/wk-form4_1745856163.xml Price: 266.95, Change:...

12:09 PM EDT, 04/28/2025 (MT Newswires) -- Castle Biosciences ( CSTL ) said Monday its DecisionDx-Melanoma clinical test for patients with cutaneous melanoma reached 200,000 orders. The 31-gene expression profile test offers personalized results detailing a patient's predicted risk of recurrence or metastasis, the company said. Shares were down 2.8% in recent trading. Price: 20.05, Change: -0.58, Percent Change: -2.84...